Skip to main content
David Barbie, MD, Oncology, Boston, MA

DavidBarbieMD

Oncology Boston, MA

Assistant Professor, Medicine-Brigham & Women's Hospital, Harvard Medical School

Dr. Barbie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Barbie's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Dana 1234
    Boston, MA 02215
    Phone+1 617-632-3468
    Fax+1 617-632-5786

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2002 - 2005
  • Harvard Medical School
    Harvard Medical SchoolClass of 2002

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid Tumors  
    Jeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
  • Tumor Innate Immunity Primed by Specific Interferon-Stimulated Endogenous Retroviruses  
    Scott Rodig, Ewa Sicinska, Thanh Uyen Barbie, David Allen Barbie, Russell William Jenkins, Ravindra Uppaluri, Rohit Thummalapalli, Jacob Sands, Nature

Press Mentions

  • Lung Cancer Research Foundation and the International Association for the Study of Lung Cancer Announce First Team Science Award Grant
    Lung Cancer Research Foundation and the International Association for the Study of Lung Cancer Announce First Team Science Award GrantNovember 19th, 2024
  • Gut Bacteria Engineered to Act as Tumor GPS for Immunotherapies
    Gut Bacteria Engineered to Act as Tumor GPS for ImmunotherapiesOctober 4th, 2024
  • Health News - Experts Convene at CSHL to Scrutinize, Assess Low-Dose CT Screening for Lung Cancer
    Health News - Experts Convene at CSHL to Scrutinize, Assess Low-Dose CT Screening for Lung CancerFebruary 10th, 2016